NCT03540264 is a NA clinical trial of Clearfil Majesty TM in Dental Wear, sponsored by Cliniques universitaires Saint-Luc- Université Catholique de Louvain.

Who is sponsoring NCT03540264?

NCT03540264 is sponsored by Cliniques universitaires Saint-Luc- Université Catholique de Louvain.

What drugs are being tested in NCT03540264?

Interventions in NCT03540264: Clearfil Majesty TM, Vita-Enamic®.

What condition does NCT03540264 study?

NCT03540264 studies Dental Wear.

Is NCT03540264 still recruiting?

NCT03540264 is currently status unknown. Last updated 11 March 2019.

Last reviewed 2019-03-11 · How we verify

NCT03540264

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Tooth Wear:m Tooth Wear : Diagnosis- Treatment Decision

Status unknown NA Last updated 11 March 2019

What this trial tests

NA trial testing Clearfil Majesty TM in Dental Wear in 52 participants. Status unknown.

Timeline

26 February 2018

Primary endpoint
31 December 2020

31 December 2020

Quick facts

Lead sponsor	Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	52
Start date	26 February 2018
Primary completion	31 December 2020
Estimated completion	31 December 2020
Sites	1 location across Belgium

Drugs / interventions tested

Clearfil Majesty TM
Vita-Enamic®

Conditions studied

Dental Wear — all drugs for Dental Wear →

Sponsor

Cliniques universitaires Saint-Luc- Université Catholique de Louvain — full company profile →

Who can join

18 and older, any sex, with Dental Wear. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Tooth wear is a physiological process occurring from normal functioning of the dentition throughout lifetime.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Cliniques universitaires Saint-Luc- Université Catholique de Louvain trials

Trials by the same sponsor.

NCT07464938 — New Tools and Predictive Markers in the Prognosis of Hypoxic-ischemic Encephalopathy Following Cardiac Arrest · NA · recruiting
NCT07173036 — Evaluation of (Cardio)Metabolic and Auxological Outcomes of GHD Patients Under rhGH or LAGH With Stratification Accordin · NA · not yet recruiting
NCT07245745 — Prospective Clinical Study Comparing PROMS After Adaptive or Conventional Radiotherapy in Prostate Cancer · NA · recruiting
NCT07588490 — Treatment of Acute Low Back Pain With Transcutaneous Electrical Neurostimulation in Emergency Departments · NA · recruiting
NCT07161219 — Implementation of New Exercise Protocols in Cardiac Rehabilitation. · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03540264 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Last refreshed: 11 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03540264.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing